5 Stocks to Own for the Surge in Coronavirus Variants

Although the pandemic has mostly faded from the front pages, mutations of the SARS-CoV-2 virus are increasing the odds that COVID will make a resurgence this winter. Add in many Americans' hesitancy over vaccines, and it appears the companies providing testing, treatments, and vaccine boosters could remain a part of our lives longer than it seemed only a few months ago.

That's why Fulgent Genetics (NASDAQ: FLGT), Lucira Health (NASDAQ: LHDX), Abbott Labs (NYSE: ABT), Roche Holdings (OTC: RHHBY), and BioNTech (NASDAQ: BNTX) are on my watch list as cases start climbing. Here's how each company could profit from the continuing efforts to end the pandemic.

Image source: Getty Images.

Continue reading

Source Fool.com